Page last updated: 2024-08-24

milnacipran and Fibromyalgia

milnacipran has been researched along with Fibromyalgia in 69 studies

Research

Studies (69)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	16 (23.19)	29.6817
2010's	46 (66.67)	24.3611
2020's	7 (10.14)	2.80

Authors

Authors	Studies
Doucette, JA; Eguale, T; Farag, HM; Goswami, H; Sultan, I; Yunusa, I	1
Flynn, D	1
Dualé, C; Giron, F; Macian, N; Pickering, G	1
Derayea, SM; Mostafa, IM; Nagy, DM; Omar, MA	1
Abdel Fattah, YH; Elnemr, R	1
Broderick, JE; Junghaenel, DU; Ono, M; Schneider, S; Stone, AA	1
Clauw, DJ; Harper, DE; Harris, RE; Harte, SE; Ichesco, E; Mawla, I; Pauer, L; Peltier, SJ	1
Jo, A; Marlow, NM; Short, EB; Simpson, KN; Vaughn, IA; Zoller, JS	1
Häuser, W; Klose, P; Üçeyler, N; Walitt, B; Welsch, P	1
Cardot, JM; Delage, N; Dualé, C; Giron, F; Macian, N; Marcaillou, F; Pereira, B; Picard, P; Pickering, G; Sickout-Arondo, S	1
Copolov, DL; Hope, J; Keks, NA; Keogh, S	1
Fusco, ML; Gentile, S	1
Häuser, W; Tort, S; Uçeyler, N; Urrútia, G; Walitt, B	1
Ang, DC; Gracely, RH; Hilligoss, J; Jensen, MP; Saha, C; Steiner, JL	1
Arnold, LM; Ma, Y; Palmer, RH	1
Albrecht, KL; Bernstein, CD; Marcus, DA	1
Altamirano, A; Gandhi, SJ; Williams, GW	1
Clauw, DJ; Mease, PJ; Palmer, RH; Trugman, JM; Wang, Y	1
Ma, Y; Palmer, RH; Trugman, JM	1
Mease, PJ; Palmer, RH; Wang, Y	1
Carville, S; Choy, E; Fransson, P; Gracely, RH; Ingvar, M; Jensen, KB; Kosek, E; Marcus, H; Petzke, F; Vitton, O; Williams, SC	1
Clauw, DJ; Hampson, JP; Harris, RE; Harte, S; Ichesco, E; Kairys, A; Peltier, S; Schmidt-Wilcke, T	1
Cappelleri, JC; Clair, AG; Cook, JP; Eisenberg, DF; Gu, T; Masters, ET; Placzek, HE; Wasser, TE	1
Dubray, C; Macian, N; Pereira, B; Pickering, G; Shinjo, C	1
Lucas, YE; Price, DD; Robinson, ME; Staud, R	1
Arnold, LM; Bateman, L; Lin, Y; Palmer, RH	1
Derry, S; Moore, RA; Phillips, T; Wiffen, PJ	1
Abtroun, L; Bunouf, P; Gendreau, RM; Vitton, O	1
Blate, M; Coplan, JD; Kang, G; Lange, G; Mao, X; Natelson, BH; Shungu, DC; Togo, F; Vu, D; Weiduschat, N	1
Aamir, R; Ahmed, M; Jishi, Z; Scharf, MB	1
Cording, M; Derry, S; Moore, RA; Phillips, T; Wiffen, PJ	1
Lee, YH; Song, GG	1
Antokhin, EY; Drobizhev, MY; Fedotova, AV; Kikta, SV	1
Clauw, DJ; Gendreau, RM; Mease, P; Palmer, RH; Wang, Y	1
Chen, W; Clauw, DJ; Gendreau, RM; Kranzler, J; Mease, PJ; Palmer, RH; Rao, SG	1
Owen, RT	1
Lindsley, CW	1
Bennett, RM	1
Mainguy, Y	1
Kim, SH; Mun, H; Park, KU; Song, J	1
Rao, SG	1
Chen, W; Clauw, DJ; Gendreau, RM; Goldenberg, DL; Mease, P; Palmer, RH	1
Chwieduk, CM; McCormack, PL	1
Briley, M	1
Branco, JC; Mainguy, Y; Perrot, S; Zachrisson, O	1
Johnson, WG; Souayah, N; Yacoub, HA	1
Bitter, I; Karamustafalioglu, O; Koponen, H; Mohr, P; Sartorius, N; Seifritz, E; Svestka, J	1
Clauw, DJ; Geisser, ME; Gendreau, MR; Palmer, R; Strand, V; Williams, DA	1
Häuser, W; Petzke, F; Sommer, C	1
Arnold, LM; Gendreau, JF; Gendreau, RM; Palmer, RH; Wang, Y	1
Dugan, BD; Kyle, JA; Testerman, KK	1
Häuser, W; Petzke, F; Sommer, C; Üçeyler, N	1
Bouroubi, A; Branco, JC; Cherin, P; Montagne, A	1
Thiessen, CN; Traynor, AP; Traynor, LM	1
Palmer, RH	1
Arora, V; Chopra, K; Kuhad, A	1
Dundon, K; Mease, PJ; Sarzi-Puttini, P	1
Rizzi, M; Sarzi-Puttini, P; Spaeth, M	1
Derry, S; Gill, D; Moore, RA; Phillips, T	1
Arnold, LM; Chen, W; Gendreau, RM; Palmer, RH; Saxe, PA	1
Hopkins, CR	1
Miyako, H; Toyofuku, A	1
Gendreau, J; Gendreau, M; Kranzler, J; Rao, SG; Vitton, O	1
Clauw, DJ; Gendreau, JF; Gendreau, RM; Gracely, RH; Kranzler, JD; McLean, SA; Mease, PJ; Ribeiro, S; Thorn, MD; Williams, DA	1
Clauw, DJ; Gendreau, RM; Gracely, RH; Harris, RE; Hufford, M; McLean, SA; Sen, A; Williams, DA	1
Brooks, VL; Leo, RJ	1
Simon, LS	1
Han, C; Marks, DC; Masand, PS; Pae, CU; Patkar, AA	1

Reviews

22 review(s) available for milnacipran and Fibromyalgia

Article	Year
Comparison of Amitriptyline and US Food and Drug Administration-Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis. JAMA network open, 2022, 05-02, Volume: 5, Issue:5 Topics: Amitriptyline; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Network Meta-Analysis; Pain; Pregabalin; United States; United States Food and Drug Administration	2022
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. The Cochrane database of systematic reviews, 2018, 02-28, Volume: 2 Topics: Adrenergic Uptake Inhibitors; Adult; Carnitine; Cyclopropanes; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Norepinephrine; Pregabalin; Quality of Life; Selective Serotonin Reuptake Inhibitors; Syndrome	2018
Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2018, Volume: 26, Issue:5 Topics: Depressive Disorder, Major; Fibromyalgia; Humans; Milnacipran; Serotonin and Noradrenaline Reuptake Inhibitors	2018
Managing fibromyalgia syndrome in pregnancy no bridges between USA and EU. Archives of women's mental health, 2019, Volume: 22, Issue:6 Topics: Anti-Anxiety Agents; Duloxetine Hydrochloride; Europe; Female; Fibromyalgia; Humans; Milnacipran; Pregabalin; Pregnancy; Pregnancy Complications; Risk Assessment; Serotonin and Noradrenaline Reuptake Inhibitors; United States	2019
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. The Cochrane database of systematic reviews, 2013, Jan-31, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Norepinephrine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Syndrome; Thiophenes	2013
Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:7 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Chronic Disease; Cyclopropanes; Depression; Fatigue; Fibromyalgia; Humans; Milnacipran; Pain Management; Selective Serotonin Reuptake Inhibitors; Weight Loss	2013
Milnacipran for neuropathic pain in adults. The Cochrane database of systematic reviews, 2015, Jul-06, Issue:7 Topics: Adult; Analgesics; Back Pain; Chronic Pain; Cyclopropanes; Fibromyalgia; Humans; Milnacipran; Neuralgia; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2015
Milnacipran for pain in fibromyalgia in adults. The Cochrane database of systematic reviews, 2015, Oct-20, Issue:10 Topics: Adult; Analgesics; Chronic Disease; Cyclopropanes; Fibromyalgia; Humans; Milnacipran; Neuralgia; Selective Serotonin Reuptake Inhibitors	2015
Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials. Rheumatology international, 2016, Volume: 36, Issue:5 Topics: Analgesics; Cyclopropanes; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Network Meta-Analysis; Pregabalin; Randomized Controlled Trials as Topic; Treatment Outcome	2016
[Between depression and fibroniyalgia: the fate of the antidepressant]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2016, Volume: 116, Issue:4 Topics: Antidepressive Agents; Cyclopropanes; Depressive Disorder; Fatigue; Fibromyalgia; Humans; Milnacipran; Pain; Russia; Serotonin and Noradrenaline Reuptake Inhibitors	2016
Milnacipran hydrochloride: its efficacy, safety and tolerability profile in fibromyalgia syndrome. Drugs of today (Barcelona, Spain : 1998), 2008, Volume: 44, Issue:9 Topics: Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Fibromyalgia; Humans; Milnacipran; Selective Serotonin Reuptake Inhibitors; Syndrome	2008
Current progress in the pharmacological therapy of fibromyalgia. Expert opinion on investigational drugs, 2009, Volume: 18, Issue:10 Topics: Adrenergic Uptake Inhibitors; Analgesics; Animals; Clinical Trials as Topic; Cyclopropanes; Drugs, Investigational; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Selective Serotonin Reuptake Inhibitors; Thiophenes	2009
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. The journal of pain, 2010, Volume: 11, Issue:6 Topics: Analgesics; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome	2010
Milnacipran for treatment of fibromyalgia. The Annals of pharmacotherapy, 2010, Volume: 44, Issue:9 Topics: Animals; Cyclopropanes; Dose-Response Relationship, Drug; Fibromyalgia; Humans; Milnacipran; Selective Serotonin Reuptake Inhibitors	2010
Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology (Oxford, England), 2011, Volume: 50, Issue:3 Topics: Amitriptyline; Antidepressive Agents; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Thiophenes; Treatment Outcome	2011
Pharmacotherapy of fibromyalgia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Jul-15, Volume: 68, Issue:14 Topics: Analgesics; Animals; Antidepressive Agents; Clinical Trials as Topic; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Thiophenes	2011
Neoteric pharmacotherapeutic targets in fibromyalgia. Expert opinion on therapeutic targets, 2011, Volume: 15, Issue:11 Topics: Animals; Cyclopropanes; Drug Approval; Drug Delivery Systems; Drug Design; Duloxetine Hydrochloride; Female; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Thiophenes; United States; United States Food and Drug Administration	2011
Pharmacotherapy of fibromyalgia. Best practice & research. Clinical rheumatology, 2011, Volume: 25, Issue:2 Topics: Analgesics; Chronic Pain; Clinical Trials as Topic; Cognition Disorders; Cyclopropanes; Duloxetine Hydrochloride; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Mood Disorders; Pain Management; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Syndrome; Thiophenes; Treatment Outcome	2011
Fibromyalgia and sleep. Best practice & research. Clinical rheumatology, 2011, Volume: 25, Issue:2 Topics: Analgesics; Central Nervous System Sensitization; Chronic Pain; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Physical Therapy Modalities; Polysomnography; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Syndrome; Thiophenes	2011
Milnacipran for neuropathic pain and fibromyalgia in adults. The Cochrane database of systematic reviews, 2012, Mar-14, Issue:3 Topics: Adult; Analgesics; Chronic Disease; Cyclopropanes; Fibromyalgia; Humans; Milnacipran; Neuralgia; Selective Serotonin Reuptake Inhibitors	2012
ACS chemical neuroscience molecule spotlight on savella. ACS chemical neuroscience, 2010, May-19, Volume: 1, Issue:5 Topics: Adrenergic Uptake Inhibitors; Cyclopropanes; Drug Approval; Fibromyalgia; Humans; Milnacipran; Selective Serotonin Reuptake Inhibitors; United States; United States Food and Drug Administration	2010
Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain. Current opinion in investigational drugs (London, England : 2000), 2006, Volume: 7, Issue:7 Topics: Adrenergic Uptake Inhibitors; Cyclopropanes; Fibromyalgia; Humans; Milnacipran; Pain; Selective Serotonin Reuptake Inhibitors	2006

Trials

28 trial(s) available for milnacipran and Fibromyalgia

Article	Year
Non-specific analgesia during a clinical trial in fibromyalgia. European journal of clinical investigation, 2020, Volume: 50, Issue:11 Topics: Adult; Analgesics, Non-Narcotic; Cognition; Double-Blind Method; Female; Fibromyalgia; Humans; Middle Aged; Milnacipran; Neuropsychological Tests; Pain Threshold; Postsynaptic Potential Summation; Sensory Thresholds	2020
Efficacy of pregabalin as a monotherapy versus combined pregabalin and milnacipran in the management of fibromyalgia. International journal of rheumatic diseases, 2020, Volume: 23, Issue:11 Topics: Adult; Analgesics, Non-Narcotic; Chronic Pain; Cost of Illness; Drug Therapy, Combination; Egypt; Female; Fibromyalgia; Humans; Milnacipran; Pain Measurement; Pregabalin; Sleep; Time Factors; Treatment Outcome	2020
III. Detecting Treatment Effects in Clinical Trials With Different Indices of Pain Intensity Derived From Ecological Momentary Assessment. The journal of pain, 2021, Volume: 22, Issue:4 Topics: Adult; Aged; Analgesics, Non-Narcotic; Ecological Momentary Assessment; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Pain Measurement; Patient Outcome Assessment; Randomized Controlled Trials as Topic; Severity of Illness Index	2021
Prediction of Differential Pharmacologic Response in Chronic Pain Using Functional Neuroimaging Biomarkers and a Support Vector Machine Algorithm: An Exploratory Study. Arthritis & rheumatology (Hoboken, N.J.), 2021, Volume: 73, Issue:11 Topics: Adult; Analgesics; Biomarkers; Brain; Chronic Pain; Cross-Over Studies; Double-Blind Method; Female; Fibromyalgia; Humans; Magnetic Resonance Imaging; Middle Aged; Milnacipran; Neuroimaging; Pregabalin; Support Vector Machine; Treatment Outcome; Young Adult	2021
Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study. Drug design, development and therapy, 2018, Volume: 12 Topics: Adult; Analgesics, Non-Narcotic; Double-Blind Method; Female; Fibromyalgia; France; Humans; Middle Aged; Milnacipran; Pain Measurement; Pain Perception; Pain Threshold; Prospective Studies; Treatment Outcome	2018
Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: a feasibility randomized-controlled trial. The Clinical journal of pain, 2013, Volume: 29, Issue:9 Topics: Adolescent; Adult; Aged; Cognitive Behavioral Therapy; Cyclopropanes; Depression; Double-Blind Method; Feasibility Studies; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Outcome Assessment, Health Care; Pain Measurement; Pain Perception; Selective Serotonin Reuptake Inhibitors; Time Factors; Young Adult	2013
A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia. The Clinical journal of pain, 2013, Volume: 29, Issue:12 Topics: Adolescent; Adult; Aged; Analgesics; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibromyalgia; Humans; Longitudinal Studies; Male; Middle Aged; Milnacipran; Pain Measurement; Patient Satisfaction; Treatment Outcome	2013
Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial. Arthritis research & therapy, 2013, Aug-16, Volume: 15, Issue:4 Topics: Adrenergic Uptake Inhibitors; Cyclopropanes; Double-Blind Method; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Pain Measurement; Time Factors; Treatment Outcome	2013
Milnacipran effects on 24-hour ambulatory blood pressure and heart rate in fibromyalgia patients: a randomized, placebo-controlled, dose-escalation study. Current medical research and opinion, 2014, Volume: 30, Issue:4 Topics: Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cyclopropanes; Double-Blind Method; Female; Fibromyalgia; Heart Rate; Humans; Male; Middle Aged; Milnacipran	2014
Effects of milnacipran on the multidimensional aspects of fatigue and the relationship of fatigue to pain and function: pooled analysis of 3 fibromyalgia trials. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014, Volume: 20, Issue:4 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Cyclopropanes; Double-Blind Method; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Pain; Pain Measurement; Randomized Controlled Trials as Topic; Treatment Outcome	2014
Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia. The journal of pain, 2014, Volume: 15, Issue:12 Topics: Adolescent; Adult; Antidepressive Agents; Brain; Cyclopropanes; Double-Blind Method; Female; Fibromyalgia; Humans; Magnetic Resonance Imaging; Middle Aged; Milnacipran; Pain; Pain Measurement; Pain Perception; Placebo Effect; Pressure; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult	2014
Resting state connectivity correlates with drug and placebo response in fibromyalgia patients. NeuroImage. Clinical, 2014, Volume: 6 Topics: Adult; Brain; Brain Mapping; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Fibromyalgia; Humans; Magnetic Resonance Imaging; Middle Aged; Milnacipran; Placebos; Rest; Selective Serotonin Reuptake Inhibitors	2014
Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial. Trials, 2015, Apr-03, Volume: 16 Topics: Adult; Clinical Protocols; Cyclopropanes; Double-Blind Method; Female; Fibromyalgia; France; Hospitals, University; Humans; Milnacipran; Neural Inhibition; Pain; Pain Management; Pain Measurement; Prospective Studies; Selective Serotonin Reuptake Inhibitors	2015
Effects of milnacipran on clinical pain and hyperalgesia of patients with fibromyalgia: results of a 6-week randomized controlled trial. The journal of pain, 2015, Volume: 16, Issue:8 Topics: Adult; Analysis of Variance; Area Under Curve; Cyclopropanes; Double-Blind Method; Female; Fibromyalgia; Humans; Hyperalgesia; Male; Middle Aged; Milnacipran; Pain Threshold; Physical Stimulation; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome; Visual Analog Scale	2015
Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program. Pediatric rheumatology online journal, 2015, Jun-26, Volume: 13 Topics: Adolescent; Adrenergic Uptake Inhibitors; Cyclopropanes; Double-Blind Method; Early Termination of Clinical Trials; Female; Fibromyalgia; Humans; Male; Milnacipran; Treatment Outcome	2015
Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial. The journal of pain, 2015, Volume: 16, Issue:11 Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Inflammatory Agents, Non-Steroidal; Attention; Biomarkers; Cerebral Ventricles; Cyclopropanes; Double-Blind Method; Executive Function; Female; Fibromyalgia; Humans; Lactic Acid; Middle Aged; Milnacipran; Nonlinear Dynamics; Pain; Pain Measurement; Proton Magnetic Resonance Spectroscopy; Psychological Tests; Selective Serotonin Reuptake Inhibitors	2015
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2016, Volume: 12, Issue:1 Topics: Adult; Aged; Cross-Over Studies; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Patient Satisfaction; Polysomnography; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sleep Wake Disorders; Treatment Outcome	2016
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clinical therapeutics, 2008, Volume: 30, Issue:11 Topics: Adult; Aged; Capsules; Constipation; Cyclopropanes; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Pain; Pain Measurement; Patient Satisfaction; Placebos; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Vomiting	2008
The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. The Journal of rheumatology, 2009, Volume: 36, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Cognition Disorders; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fatigue Syndrome, Chronic; Female; Fibromyalgia; Headache; Humans; Male; Middle Aged; Milnacipran; Muscle, Skeletal; Nausea; Pain Measurement; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2009
Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study. Pain medicine (Malden, Mass.), 2010, Volume: 11, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibromyalgia; Follow-Up Studies; Humans; Male; Middle Aged; Milnacipran; Pain Measurement; Treatment Outcome; Young Adult	2010
A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. The Journal of rheumatology, 2010, Volume: 37, Issue:4 Topics: Adult; Aged; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Pain; Pain Measurement; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome	2010
Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Pain, 2010, Volume: 149, Issue:2 Topics: Activities of Daily Living; Adult; Cognition Disorders; Cyclopropanes; Depressive Disorder; Drug Resistance; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Outcome Assessment, Health Care; Pain Measurement; Patient Satisfaction; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Treatment Outcome	2010
Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis and rheumatism, 2010, Volume: 62, Issue:9 Topics: Adolescent; Adult; Aged; Cyclopropanes; Double-Blind Method; Female; Fibromyalgia; Health Status; Humans; Male; Middle Aged; Milnacipran; Pain; Pain Measurement; Patient Satisfaction; Placebos; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Young Adult	2010
Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study. The Journal of rheumatology, 2011, Volume: 38, Issue:7 Topics: Adolescent; Adult; Aged; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Female; Fibromyalgia; Humans; Longitudinal Studies; Male; Middle Aged; Milnacipran; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult	2011
Short-term (2-week) effects of discontinuing milnacipran in patients with fibromyalgia. Current medical research and opinion, 2012, Volume: 28, Issue:5 Topics: Adult; Blood Pressure; Cyclopropanes; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Pain; Treatment Outcome	2012
A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Human psychopharmacology, 2004, Volume: 19 Suppl 1 Topics: Antidepressive Agents; Cyclopropanes; Double-Blind Method; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Patient Compliance	2004
Efficacy of milnacipran in patients with fibromyalgia. The Journal of rheumatology, 2005, Volume: 32, Issue:10 Topics: Analgesics; Antidepressive Agents, Tricyclic; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Pain; Pain Measurement; Selective Serotonin Reuptake Inhibitors; Sickness Impact Profile; Treatment Outcome	2005
Characterization and consequences of pain variability in individuals with fibromyalgia. Arthritis and rheumatism, 2005, Volume: 52, Issue:11 Topics: Cyclopropanes; Data Collection; Female; Fibromyalgia; Humans; Male; Medical Records Systems, Computerized; Middle Aged; Milnacipran; Pain; Pain Measurement; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors	2005

Other Studies

19 other study(ies) available for milnacipran and Fibromyalgia

Article	Year
Chronic Pain Syndromes: Fibromyalgia. FP essentials, 2023, Volume: 533 Topics: Chronic Pain; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Milnacipran; Pregabalin	2023
Use of Hantzsch reaction for quantitation of milnacipran as a magic treatment for fibromyalgia syndrome in human plasma and urine. Luminescence : the journal of biological and chemical luminescence, 2021, Volume: 36, Issue:1 Topics: Fibromyalgia; Formaldehyde; Humans; Milnacipran; Spectrometry, Fluorescence; Tablets	2021
Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators. Pain practice : the official journal of World Institute of Pain, 2018, Volume: 18, Issue:2 Topics: Adolescent; Adult; Aged; Cohort Studies; Databases, Factual; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Fibromyalgia; Health Care Costs; Humans; Male; Medication Adherence; Middle Aged; Milnacipran; Pregabalin; Retrospective Studies; Venlafaxine Hydrochloride	2018
An acute neurological syndrome with cerebrovascular and parkinsonian clinical features associated with perioperative SNRI withdrawal. Journal of neurosurgical anesthesiology, 2013, Volume: 25, Issue:3 Topics: Adrenergic Uptake Inhibitors; Adult; Cerebrovascular Disorders; Cyclopropanes; Diskectomy; Fibromyalgia; Humans; Male; Milnacipran; Parkinsonian Disorders; Perioperative Period; Selective Serotonin Reuptake Inhibitors; Spinal Fusion; Stroke; Substance Withdrawal Syndrome	2013
Prior authorization in the treatment of patients with pDPN and FM. Pain practice : the official journal of World Institute of Pain, 2015, Volume: 15, Issue:1 Topics: Adult; Aged; Analgesics; Cohort Studies; Cost of Illness; Cyclopropanes; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Fibromyalgia; Health Care Costs; Health Services; Humans; Insurance Claim Review; Insurance, Health; Insurance, Pharmaceutical Services; Longitudinal Studies; Male; Middle Aged; Milnacipran; Pregabalin; Retrospective Studies; Selective Serotonin Reuptake Inhibitors	2015
Is the Efficacy of Milnacipran in Fibromyalgia Predictable? A Data-Mining Analysis of Baseline and Outcome Variables. The Clinical journal of pain, 2016, Volume: 32, Issue:5 Topics: Adrenergic Uptake Inhibitors; Clinical Trials, Phase III as Topic; Cluster Analysis; Cyclopropanes; Data Mining; Female; Fibromyalgia; Humans; Male; Milnacipran; Pain Measurement; Psychiatric Status Rating Scales; Surveys and Questionnaires; Treatment Outcome	2016
Molecule of the month. FDA approves new treatment for fibromyalgia. Current topics in medicinal chemistry, 2009, Volume: 9, Issue:2 Topics: Cyclopropanes; Drug Approval; Fibromyalgia; Humans; Milnacipran; United States; United States Food and Drug Administration	2009
Fibromyalgia: a new treatment option for fibromyalgia. Nature reviews. Rheumatology, 2009, Volume: 5, Issue:4 Topics: Adrenergic Uptake Inhibitors; Cyclopropanes; Fibromyalgia; Humans; Milnacipran	2009
Functional magnetic resonance imagery (fMRI) in fibromyalgia and the response to milnacipran. Human psychopharmacology, 2009, Volume: 24 Suppl 1 Topics: Adolescent; Adult; Brain; Brain Mapping; Cyclopropanes; Female; Fibromyalgia; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Milnacipran; Oxygen; Pain Measurement; Pain Threshold; Selective Serotonin Reuptake Inhibitors; Time Factors; Young Adult	2009
Milnacipran (savella) for fibromyalgia. The Medical letter on drugs and therapeutics, 2009, Jun-15, Volume: 51, Issue:1314 Topics: Adrenergic Uptake Inhibitors; Cognition; Cyclopropanes; Drug Approval; Drug Interactions; Fibromyalgia; Humans; Milnacipran; Muscle Fatigue; Pain; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration	2009
Effect of the combined use of tramadol and milnacipran on pain threshold in an animal model of fibromyalgia. The Korean journal of internal medicine, 2009, Volume: 24, Issue:2 Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Behavior, Animal; Cyclopropanes; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fibromyalgia; Hydrogen-Ion Concentration; Hyperalgesia; Injections, Intraperitoneal; Male; Milnacipran; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Sodium Chloride; Time Factors; Tramadol	2009
Milnacipran: in fibromyalgia. Drugs, 2010, Volume: 70, Issue:1 Topics: Animals; Bronchodilator Agents; Cognition Disorders; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fibromyalgia; Humans; Meta-Analysis as Topic; Milnacipran; Muscle Relaxants, Central; Muscle, Skeletal; Nausea; Norepinephrine; Pain; Pain Measurement; Patient Compliance; Patient Satisfaction; Placebos; Sex Factors; Time Factors; Treatment Outcome	2010
Drugs to treat fibromyalgia - the transatlantic difference. Current opinion in investigational drugs (London, England : 2000), 2010, Volume: 11, Issue:1 Topics: Adrenergic Uptake Inhibitors; Analgesics; Cyclopropanes; Drug Approval; Duloxetine Hydrochloride; European Union; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Off-Label Use; Pregabalin; Thiophenes; United States; United States Food and Drug Administration	2010
Serotonin syndrome after administration of milnacipran for fibromyalgia. Neurology, 2010, Feb-23, Volume: 74, Issue:8 Topics: Aged; Cyclopropanes; Cyproheptadine; Fibromyalgia; Humans; Male; Milnacipran; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome	2010
Management of depression in the presence of pain symptoms. Psychiatria Danubina, 2010, Volume: 22, Issue:1 Topics: Antidepressive Agents; Brain; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Mind-Body Relations, Metaphysical; Norepinephrine; Pain; Psychotherapy; Serotonin; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride	2010
Correction: milnacipran for treatment of fibromyalgia. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:6 Topics: Clinical Trials as Topic; Cyclopropanes; Fibromyalgia; Humans; Milnacipran; Research; Review Literature as Topic	2011
A case of temporo-mandibular disorder with fibromyalgia treated with the antidepressant, milnacipran. Human psychopharmacology, 2004, Volume: 19, Issue:5 Topics: Adult; Antidepressive Agents; Cyclopropanes; Dose-Response Relationship, Drug; Female; Fibromyalgia; Humans; Milnacipran; Temporomandibular Joint Disorders	2004
Is milnacipran effective in treating pain in patients with fibromyalgia? Nature clinical practice. Rheumatology, 2006, Volume: 2, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Cyclopropanes; Drug Therapy, Combination; Fibromyalgia; Humans; Middle Aged; Milnacipran; Pain; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	2006
Duloxetine: an emerging evidence for fibromyalgia. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2009, Volume: 63, Issue:1 Topics: Analgesics; Antidepressive Agents; Cyclopropanes; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Pregabalin; Randomized Controlled Trials as Topic; Thiophenes	2009